iSpecimen (NASDAQ: ISPC) — Perfil da empresa, notícias e dados financeiros
iSpecimen provides researchers with biospecimens, improving access to high-quality specimens for medical research.
iSpecimen
iSpecimen (NASDAQ:ISPC) operates at the intersection of technology and bioscience by providing researchers with biospecimens they need for their studies, such as blood, tissues, and cells. The company harnesses technology to streamline the procurement process, making it more efficient for both suppliers and researchers. iSpecimen's projects predominantly focus on improving the availability of high-quality specimens from a diverse population, thereby fostering advancements in medical research and personalized medicine. Objectives include expanding its global network of healthcare providers, enhancing its proprietary technology platform for better user experience, and ultimately contributing to scientific discoveries by ensuring the seamless collection and distribution of specimens.
Resumo
Operações
Produtos e/ou serviços de iSpecimen
- Human Biospecimen Procurement - A service streamlining access to a diverse range of human biospecimens for biomedical research.
- Marketplace Platform - An online marketplace connecting researchers with biospecimen suppliers.
- Custom Collection Services - Tailored biospecimen collection and processing services to meet specific research needs.
- Technology Solutions - Proprietary software tools designed to simplify biospecimen procurement, management, and compliance tracking.
- Data Services - Analytical and data management services to enhance research outcomes and insights from biospecimen data.
- Consulting and Support - Expert consulting services guiding researchers through biospecimen acquisition, regulatory compliance, and project management.
equipe executiva do iSpecimen
- Yuying LiangChief Financial Officer
- Shahin BehroyanChief Executive Officer
Principais indicadores financeiros
Resultados divulgados pela iSpecimen, em USD.
- Cap. de mercado
- 2,2 mi
- Receita (TTM)
- 466,3 mil
- P/L
- —
- LPA (diluído, TTM)
- -53.0
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 1,9 mi | -9 mi | -10,5 mi | |
| 9,3 mi | -12,7 mi | -12,5 mi | |
| 9,9 mi | -11,2 mi | -11,1 mi | |
| 10,4 mi | -10,2 mi | -10,2 mi |